Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sleep Wake Disorders × Methadone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 2 Vomiting 1 Sleep Wake Disorders 1 Neoplasms 1 Nausea 1 Cancer Pain 1 Breakthrough Pain 1

Interventions

N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide 1 Methadone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00930332 2024-02-12

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Canadian Cancer Trials Group

Phase 1 Terminated

Nausea, Pain, Sleep Wake Disorders, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡